GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Clinical trials for GASTROESOPHAGEAL REFLUX DISEASE (GERD) explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL REFLUX DISEASE (GERD) trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL REFLUX DISEASE (GERD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
A tiny stomach tweak may calm reflux after weight-loss surgery — but does it hold up?
Disease control CompletedThis study looks at whether a procedure called endoscopic cardia banding plication (ECBP) can help people who still have severe heartburn and reflux after having a sleeve gastrectomy for obesity. The procedure narrows the opening between the stomach and esophagus using bands, wit…
Matched conditions: GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New surgical stapler tested in GERD study shows promise
Disease control CompletedThis study tested a special stapler during a combined weight-loss and anti-reflux surgery called Nissen Sleeve. It involved 167 people with obesity and GERD. The goal was to see if the surgery reduces acid reflux and if the stapler works safely.
Matched conditions: GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Phase: NA • Sponsor: Ezisurg Medical Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
One-Minute test could replace painful GERD diagnostics
Diagnosis CompletedThis study tested a new, faster way to diagnose GERD (heartburn disease) using a special probe during a routine endoscopy. The test takes only one minute and may be more comfortable than current methods. Fifteen adults with known reflux participated, and their results were compar…
Matched conditions: GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New hope for kids with heartburn: study tests daily pill
Symptom relief CompletedThis study tests whether a daily medicine called dexlansoprazole can safely reduce symptoms of gastroesophageal reflux disease (GERD) in children aged 2 to 11 years who have heartburn but no damage to their esophagus. About 71 children will take the medicine or a placebo for 12 w…
Matched conditions: GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Phase: PHASE2 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC